Prof. Hening Lin brings expertise in enzymes to UChicago, bridging scientists, engineers and doctors to translate research to ...

"Synthetic biology tools like optogenetics allow us to precisely tune complex cellular processes, something traditional drug screening cannot do," said Maxwell Wilson, Ph.D., Co-Founder and Chief ...

A novel optogenetic screening platform enables a high-throughput screen and identified several integrated stress response-potentiating compounds.

Molecular glues, tiny molecules that connect one protein to another, are promising targets for pharmaceutical research. By ...

A major scientific advance in protein modeling developed by Microsoft Research AI for Science, has been published in Science.

A key patent for Merck’s blockbuster drug Keytruda will expire in 2028. The cancer therapy brought the company $29.5 billion last year. Keytruda may also face “ price setting ” from the Inflation ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

The analysis reveals a strong dominance of AI applications in oncology, comprising 72.8% of all included studies. This skew ...

AssayQuant's KinSightTM Kinome profiling will be integrated into AsedaSciences' 3RnD® platform, enhancing data visualization to ac ...

The first article on phenotypic drug discovery (PDD) by Garaci et al. provides an in-depth analysis of thymosin alpha-1 as a model for investigating host-microbe interactions. By adopting a PDD ...

Justice Department worker faces capital murder charge after allegedly giving abortion drug to his pregnant girlfriend without her consent, leading to the loss of her fetus.

Over the past year, drug discovery has gotten a massive boost from the CAS BioFinder Discovery Platform, which allows scientists to explore known and predicted data that accelerate the preclinical ...